WTT accepting applications through April 16
NEW YORK, N.Y. (January 18, 2012) – World TeamTennis is currently
accepting applications from youth tennis players with diabetes for the
Novo Nordisk Donnelly Awards. The Novo Nordisk Donnelly Awards annually
distribute $25,000 in scholarships, including two one-time $5,000 national
scholarships and six one-time $2,500 regional scholarships.
The scholarships are awarded to male and female athletes ages 12-21, who
have diabetes and play tennis competitively in tournaments or on their
school team. Applications must be received by April 16, 2012, along with
two letters of recommendation and a short essay explaining the
significance of diabetes in the applicant’s life. The awards are to be
used for education, tennis development and/or medical care.
The recipients of the $5,000 national scholarships will receive their
awards at a World TeamTennis Pro League match this summer from WTT
co-founder Billie Jean King. The scholarship program was established by
King, through WTT Charities, in 1998 to encourage children with diabetes
to lead an active life and compete in tennis.
The Novo Nordisk Donnelly Awards are named after two long-time World
TeamTennis executives and tennis champions, Diane Donnelly Stone and
Tracey Donnelly Maltby, who are sisters. Stone was an All-American and
NCAA doubles champion at Northwestern University, and Maltby earned
All-Big Ten honors at the University of Iowa. Both women have lived
successfully with diabetes since childhood.
Novo Nordisk, a world leader in diabetes care, has been the title sponsor
of the award since 2002. For more details on the Novo Nordisk Donnelly
Awards and to download an application form, visit www.WTT.com/DonnellyAwards. For more information, contact Diane Donnelly Stone at firstname.lastname@example.org or 212-586-3444 ext. 20.
About Novo Nordisk:
Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 88 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk-us.com.
Diabetes Education and Camping Association